TomoTherapy Enters Into Radiation Therapy Equipment Purchasing Agreement With ROi
25 Aprile 2011 - 2:00PM
Marketwired
TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced
radiation therapy solutions for the treatment of cancer and other
diseases, today announced that it has signed a radiation therapy
equipment purchasing agreement with Resource Optimization &
Innovation (ROi), one of the healthcare industry's leading supply
chain management companies.
"Our agreement with TomoTherapy will provide ROi members with
the opportunity to secure one of the most advanced cancer fighting
technologies for their patients," said Jim Angelica, senior
contract manager at ROi.
Under this five-year contract, TomoTherapy's advanced radiation
therapy equipment will be available to ROi's more than 1,400
members, including 35 hospitals and clinics throughout Arkansas,
Illinois, Kansas, Missouri and Oklahoma.
"With daily imaging capabilities and precise delivery of
radiation, TomoTherapy® treatment systems are bringing numerous
proven treatment benefits to cancer patients around the world,"
said Fred Robertson, TomoTherapy's president and CEO. "We look
forward to working with ROi and its members to bring our technology
to new communities throughout the Midwestern U.S."
About TomoTherapy Incorporated TomoTherapy Incorporated
develops, markets and sells advanced radiation therapy solutions
that can be used to treat a wide variety of cancers, from the most
common to the most complex. The ring gantry-based TomoTherapy®
platform combines integrated CT imaging with conformal radiation
therapy to deliver sophisticated radiation treatments with speed
and precision while reducing radiation exposure to surrounding
healthy tissue. TomoTherapy's suite of solutions include its
flagship Hi-Art® treatment system, which has been used to deliver
more than three million CT-guided, helical intensity-modulated
radiation therapy (IMRT) treatment fractions; the TomoHD™ treatment
system, designed to enable cancer centers to treat a broader
patient population with a single device; and the TomoMobile™
relocatable radiation therapy solution, designed to improve access
and availability of state-of-the-art cancer care. TomoTherapy's
stock is traded on the NASDAQ Global Select Market under the symbol
TOMO. To learn more about TomoTherapy, please visit
TomoTherapy.com.
©2011 TomoTherapy Incorporated. All rights reserved.
TomoTherapy, Tomo, TomoHD, TomoMobile, TomoDirect, TQA, the
TomoTherapy logo and Hi-Art are among trademarks, service marks or
registered trademarks of TomoTherapy Incorporated in the United
States and other countries.
Investor Contact: Thomas E. Powell Chief Financial
Officer 608.824.2800 Email Contact Media Contacts: Kevin
O'Malley Director, Corporate Communications 608.824.3384 Email
Contact Susan Lehman Rockpoint Public Relations 510.832.6006 Email
Contact
Grafico Azioni Tom Online (NASDAQ:TOMO)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Tom Online (NASDAQ:TOMO)
Storico
Da Giu 2023 a Giu 2024